Unique ID issued by UMIN | UMIN000011417 |
---|---|
Receipt number | R000013367 |
Scientific Title | Local excision with postoperative chemoradiotherapy for T1, T2 rectal cancer |
Date of disclosure of the study information | 2013/08/15 |
Last modified on | 2013/08/08 10:57:56 |
Local excision with postoperative chemoradiotherapy for T1, T2 rectal cancer
T1, T2 Study
Local excision with postoperative chemoradiotherapy for T1, T2 rectal cancer
T1, T2 Study
Japan |
T1,T2 cancer of low rectum
Gastroenterology | Gastrointestinal surgery | Radiology |
Malignancy
NO
Evaluation on feasibility of local excision with chemoradiotherapy for T1,T2 lower rectal cancer.
Safety,Efficacy
Confirmatory
Phase II
Disease free survival at five years
Overall survival at five years
Local relapse-free survival
Salvage treatment and prognosis
Adverse events in chemoradiotherapy
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine | Maneuver | Other |
Local excision
Postoperative chemoradiotherapy
20 | years-old | <= |
75 | years-old | >= |
Male and Female
1. Primary rectal cancer located within lower rectum
2. Clinical T1 or T2, N0, M0
3. Tumor size within 3cm, and possible to be curative local excision
4. Without severe complications. PS(ECOG) of 0 or 1
5. Pathological proven well or moderately adenocarcinoma
6. First treatment of rectal cancer
7. Without synchronous or metachronous ( within 5 years ) malignancies
8. written informed consent
9. Aged 20 to 75 years old.
Pathological proven well or moderately adenocarcinoma in resected specimen
10. Depth of sm-massive invasion, or with lymphatic or venous vessels invasion, or depth of mp invasion
11. Pathological negative surgical margins in resected specimen
12. Enough organ functions
i. WBC count : >=3000/mm3
ii. Platelet count : >=100,000/mm3
iii. T-Bil : <=1.5mg/dl
iv. AST/ALT : <=100IU/l
v. Cr : <=1.5mg/dl
Normal ECG
1. Pathological proven poorly or mucinous adenocarcinoma by biopsy
2. Clinical N positive
3. Distant metastasis
4. PS (ECOG) 2, 3, and 4
5. Without written informed consent
6. Pathological proven poorly or mucinous adenocarcinoma in resected specimen
7. Pathological positive surgical margins in resected specimen
8. Depth of m invasion, or sm-minute invasion without vessels invasion
9. Bone marrow dysfunction
10. Be certain or suspicious pregnant
11. Precious radiotherapy in abdomino-pelvic area
12. Unsuitable patients for this study
55
1st name | |
Middle name | |
Last name | Norio Saito |
National Cancer Center Hospital East
Colorectal and Pelvic Surgery
6-5-1, Kashwanoha, Kashiwa, 277-8577, Japan
04-7133-1111
1st name | |
Middle name | |
Last name | Norio Saito |
National Cancer Center Hospital East
Colorectal and Pelvic Surgery
6-5-1, Kashwanoha, Kashiwa, 277-8577, Japan
04-7133-1111
norsaito@east.ncc.go.jp
National Cancer Center Hospital East
National Cancer Center
Other
Japan
NO
国立がん研究センター東病院(千葉県)
国立がん研究センター中央病院(東京都)
愛知県がんセンター中央病院(愛知県)
山形県立中央病院(山形県)
大阪府立成人病センター(大阪府)
新潟県立がんセンター(新潟県)
石川県立中央病院(石川県)
四国がんセンター(愛媛県)
国立病院機構九州がんセンター(福岡県)
国立病院機構名古屋医療センター(愛知県)
2013 | Year | 08 | Month | 15 | Day |
Unpublished
No longer recruiting
2002 | Year | 11 | Month | 27 | Day |
2002 | Year | 12 | Month | 01 | Day |
2015 | Year | 11 | Month | 30 | Day |
2013 | Year | 08 | Month | 08 | Day |
2013 | Year | 08 | Month | 08 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013367